RAC 2.30% $1.49 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-68

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 149 Posts.
    lightbulb Created with Sketch. 649
    https://hotcopper.com.au/data/attachments/5715/5715233-8fe5884828611e976dce7e8c6d80b8eb.jpg

    You can see the previous lines of therapy these patients had used in the announement. A number of these therapies would be considered chemotherapy includng cytarabine/dauno, idarubicine and fludarabine. Venetoclax, gilteritinib and the CAR-T would probably not be considered "chemotherapy" although the term is a bit vague.
    Last edited by JBeez_: 07/11/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.